Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Pain. 2014 Apr 13;155(7):1328–1338. doi: 10.1016/j.pain.2014.04.009

Fig. 6. PAR2 loss does not inhibit inflammation and mast cell activation in EAP mice.

Fig. 6

(A) Representative H&E staining of the prostate excised from (panel a) EAP mice and (panel b) PAR2 KO with EAP at day 30 show leukocytic influx at day 30. Also, mouse prostate sections were stained with acidified toluidine blue and showed the same number of mast cells in (panel c) B6 mice with EAP and (panel d) PAR2 KO with EAP. (B) Inflammation score was assessed from H&E staining sections of the prostates obtained from B6 EAP and PAR2 KO with EAP at day 30 and were quantified by a blinded observer. (C) Resting mast cells, partially activated, and activated mast cells were also quantified and show no difference between groups. Data reflect mean ± SEM for 3 non-serial sections from 3 animals.